Patrick Fortune, Nathalie Gosset, Anand Subramony and Ruprecht von Buttlar, Will Share Their Perspective on Commercializing Drug Delivery Technologies at NanoDDS’13
San Diego, CA, October 23, 2013 --(PR.com
)-- At NanoDDS’13 on Friday, Oct. 25 in the Health Sciences Education Center auditorium, Prof. Adah Almutairi will moderate a panel welcoming Patrick Fortune from the Cleveland Clinic Innovations, Nathalie Gosset from the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California, Anand Subramony from the Novartis Institutes for Biomedical Research and Ruprecht von Buttlar from the San Diego CONNECT. The four panelists will be invited to discuss the various aspects of commercializing drug delivery technologies.
The Nanomedicine and Drug Delivery Symposium is an annual event. This year, it takes place at the University of California Sand Diego’s Health Sciences Education Center from October 25 to 27, 2013. This symposium gathers researchers who are developing delivery vehicles for high sensitivity diagnosis and targeted drug delivery using nano technologies and materials.